Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

CD73

5′-nucleotidase (5′-NT), also known CD73 (cluster of differentiation 73), is an enzyme that in humans is encoded by the NT5E gene. CD73 commonly serves to convert AMP to adenosine. NT5E (CD73) is a surface enzyme which is expressed on multiple cells. This enzyme mediates the gradual hydrolysis of the autocrine and paracrine danger signals of ATP and ADP to anti-inflammatory adenosine. Immune suppression mediated by adenosinergic pathways is very important for maintaining immune system homeostasis.

AB-680
T102162105904-82-1
AB-680, a highly potent, reversible, and selective inhibitor of CD73 (an ectonucleotidase, Ki: 4.9 pM for hCD73) with anti-tumor activity, displays >10,000-fold selectivity over related ectonucleotidases CD39.
  • $115
In Stock
Size
QTY
Oleclumab
T766951803176-05-7
Oleclumab (MEDI9447) is a human anti-CD73 monoclonal antibody with anticancer activity that inhibits the extracellular enzyme CD73 nucleic acid exonuclease activity, inhibits the adenosine pathway, and can be used for the study of metastatic desmoplasia-resistant prostate cancer.
  • $479
In Stock
Size
QTY
MethADP
T120083768-14-7In house
MethADP (Adenosine 5'-(α,β-methylene)diphosphate) is a specific CD73 inhibitor that inhibits the enzyme ecto-5′-nucleotidase (ecto), which has been used in the study of neurological and cardiovascular diseases.
  • $198
In Stock
Size
QTY
CD73-IN-4
T92102216764-29-1
CD73-IN-4 is a potent and selective methylenephosphonic acid CD73 inhibitor.
  • $98
In Stock
Size
QTY
TargetMol | Inhibitor Sale
PSB-12379 ditriethylamine salt
T12569L In house
PSB-12379 ditriethylamine salt, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase (CD73) inhibitor with Kis of 9.03 nM (rat) and 2.21 nM (human).
  • $117
In Stock
Size
QTY
TargetMol | Inhibitor Sale
CD73-IN-3
T88752375815-63-5
CD73-IN-3 (LY-3475070) is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.
  • $58
In Stock
Size
QTY
TargetMol | Inhibitor Sale
CD73-IN-1
T107212132396-40-6
CD73-IN-1 is a CD73 inhibitor with anticancer activity.
  • $89
In Stock
Size
QTY
Dresbuxelimab
T806032550560-20-6
Dresbuxelimab (AK-119), an IgG-κ monoclonal antibody, selectively targets CD73 and is commonly produced using a Chinese Hamster Ovary (CHO) cell expression system [1].
  • Inquiry Price
Size
QTY
Mupadolimab
T767352451856-97-4
Mupadolimab (CPI-006) is a humanized FC-γR binding deficient IgG1 anti-CD73 antibody with potential anticancer activity and activation of CD73POS B cells.
  • $222
In Stock
Size
QTY